Abbott India Ltd
NSE:ABBOTINDIA
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22 135.15
30 195.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Abbott India Ltd
Cash from Financing Activities
Abbott India Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Cash from Financing Activities
-₹7.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Financing Activities
-₹3.8B
|
CAGR 3-Years
-133%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Financing Activities
-₹16.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Financing Activities
-₹58.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Financing Activities
-₹26.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Cash from Financing Activities
₹52.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott India Ltd
Glance View
Abbott India Ltd, a subsidiary of the global healthcare giant Abbott Laboratories, is a key player in the Indian pharmaceutical and healthcare industry, with a legacy that spans over seven decades. The company focuses on developing and distributing a wide range of healthcare products, including prescription medications, nutritional supplements, and diagnostics. With a strong emphasis on innovation and quality, Abbott India has established a robust portfolio of well-known brands in therapeutic areas such as cardiology, diabetes care, and women's health. Its consistent commitment to research and development, coupled with the backing of its parent company, positions Abbott India as a formidable competitor in a rapidly growing market that is increasingly shifting towards preventive care and advanced therapies. In recent years, Abbott India has demonstrated impressive growth, benefiting from rising healthcare demand driven by an expanding middle class and increasing health awareness across the country. The company's strategic investments in manufacturing, distribution, and digital health technologies enhance its ability to reach a broader consumer base and improve patient accessibility. Additionally, Abbott's strong financial health, characterized by steady revenue growth and dividend payments, makes it an attractive option for investors seeking stability and long-term value. As the Indian healthcare landscape evolves, Abbott India is poised to capitalize on emerging trends, reinforcing its reputation as a trusted brand while delivering impactful solutions to its customers.
See Also
What is Abbott India Ltd's Cash from Financing Activities?
Cash from Financing Activities
-7.4B
INR
Based on the financial report for Mar 31, 2024, Abbott India Ltd's Cash from Financing Activities amounts to -7.4B INR.
What is Abbott India Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-39%
Over the last year, the Cash from Financing Activities growth was -17%. The average annual Cash from Financing Activities growth rates for Abbott India Ltd have been -9% over the past three years , -39% over the past five years .
You don't have any saved screeners yet
